DETECTION OF THE BRAF V600E MUTATION IN COLON CARCINOMA – CRITICAL EVALUATION OF THE IMUNOHISTOCHEMICAL APPROACH

作者: Jerzy Lasota , Artur Kowalik , Bartosz Wasag , Zeng-Feng Wang , Anna Felisiak-Golabek

DOI: 10.1097/PAS.0000000000000229

关键词:

摘要: … BRAF mutation in colon carcinoma has potential as a prognostic marker and also a treatment target for new BRAF … PCR amplification products represented WT and mutant BRAF alleles, …

参考文章(24)
David Capper, Anita Voigt, Gergana Bozukova, Aysel Ahadova, Philipp Kickingereder, Andreas von Deimling, Magnus von Knebel Doeberitz, Matthias Kloor, BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer. International Journal of Cancer. ,vol. 133, pp. 1624- 1630 ,(2013) , 10.1002/IJC.28183
Walid Shaib, Reena Mahajan, Bassel El-Rayes, Markers of Resistance to anti-EGFR Therapy in Colorectal Cancer Journal of gastrointestinal oncology. ,vol. 4, pp. 308- 318 ,(2013) , 10.3978/J.ISSN.2078-6891.2013.029
Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Muranyi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi, Mutation-specific antibody detects mutant BRAFV600Eprotein expression in human colon carcinomas Cancer. ,vol. 119, pp. 2765- 2770 ,(2013) , 10.1002/CNCR.28133
Kajsa Affolter, Wade Samowitz, Sheryl Tripp, Mary P. Bronner, BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma. Genes, Chromosomes and Cancer. ,vol. 52, pp. 748- 752 ,(2013) , 10.1002/GCC.22070
Cheryl A Adackapara, Lynette M Sholl, Justine A Barletta, Jason L Hornick, Immunohistochemistry using the BRAF V600E mutation‐specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma Histopathology. ,vol. 63, pp. 187- 193 ,(2013) , 10.1111/HIS.12154
Matthias Rössle, Michèle Sigg, Jan H. Rüschoff, Peter J. Wild, Holger Moch, Achim Weber, Markus P. Rechsteiner, Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma Virchows Archiv. ,vol. 463, pp. 623- 631 ,(2013) , 10.1007/S00428-013-1492-3
Christopher W. Toon, Michael D. Walsh, Angela Chou, David Capper, Adele Clarkson, Loretta Sioson, Stephen Clarke, Scott Mead, Rhiannon J. Walters, Mark Clendenning, Christophe Rosty, Joanne P. Young, Aung Ko Win, John L. Hopper, Ashley Crook, Andreas von Deimling, Mark A. Jenkins, Daniel D. Buchanan, Anthony J. Gill, BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. The American Journal of Surgical Pathology. ,vol. 37, pp. 1592- 1602 ,(2013) , 10.1097/PAS.0B013E31828F233D
Alexandra Thiel, Mira Heinonen, Jonas Kantonen, Annette Gylling, Laura Lahtinen, Mari Korhonen, Soili Kytölä, Jukka-Pekka Mecklin, Arto Orpana, Päivi Peltomäki, Ari Ristimäki, BRAF mutation in sporadic colorectal cancer and Lynch syndrome Virchows Archiv. ,vol. 463, pp. 613- 621 ,(2013) , 10.1007/S00428-013-1470-9
Jan Sperveslage, Midea Gierke, David Capper, Jürgen Honegger, Bence Sipos, Rudi Beschorner, Jens Schittenhelm, VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathologica. ,vol. 125, pp. 911- 912 ,(2013) , 10.1007/S00401-013-1118-5
David Capper, Matthias Preusser, Antje Habel, Felix Sahm, Ulrike Ackermann, Genevieve Schindler, Stefan Pusch, Gunhild Mechtersheimer, Hanswalter Zentgraf, Andreas von Deimling, Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody Acta Neuropathologica. ,vol. 122, pp. 11- 19 ,(2011) , 10.1007/S00401-011-0841-Z